Do you still frequently use efavirenz-based regimens as initial therapy? Take the
HIV and ID Observations poll.
A treatment regimen of dolutegravir plus abacavir/3TC performed better than combination therapy with tenofovir/FTC/efavirenz in the recently published SINGLE study. However, says Dr. Paul Sax in his HIV and ID Observations blog, we are far from seeing the end of the efavirenz era globally. Do you still frequently use efavirenz-based regimens as initial therapy?